Surgical Metabolism and Nutrition : eISSN 2465-8383 / pISSN 2233-5765

Table. 3.

Table. 3.

Nutritional assessment compared with preoperative and postoperative according to patients’ sex and whether they were treated with chemotherapy

Male patients without chemotherapy (N=87)Female patients without chemotherapy (N=50)Male patients with chemotherapy (N=144)Female patients with chemotherapy (N=93)




Preoperative6 months after surgeryPreoperative6 months after surgeryPreoperative6 months after surgeryPreoperative6 months after surgery
Lymphocyte1868±6701935±6761811±5871977±6431828±6331814±6781731±5651674±619
 <1500/μL59 (67.8%)63 (72.4%)34 (68.0%)38 (76.0%)98 (68.1%)96 (66.7%)60 (64.5%)52 (55.9%)
 ≥1500/μL28 (32.2%)24 (27.6%)16 (32.0%)12 (24.0%)46 (31.9%)48 (33.3%)33 (35.5%)41 (44.1%)
Albumin4.2±0.44.2±0.34.1±0.54.2±0.34.1±0.44.1±0.33.9±0.54.1±0.3
 <3.5 g/dL85 (94.3%)85 (97.7%)46 (92.0%)50 (100%)135 (93.8%)142 (98.6%)81 (87.1%)93 (100%)
 ≥3.5 g/dL5 (5.7%)2 (2.3%)4 (8.0%)0 (0.0%)9 (6.3%)2 (1.4%)12 (12.9%)0 (0.0%)
Hemoglobin13.6±2.013.6±1.511.8±1.612.2±1.213.1±2.113.3±1.711.2±1.511.9±1.2
Anemia
 No59 (67.8%)62 (71.3%)25 (50.0%)33 (66.0%)84 (58.3%)88 (61.1%)28 (30.1%)44 (47.3%)
 Yes28 (32.2%)25 (28.7%)25 (50.0%)17 (34.0%)60 (41.7%)56 (38.9%)65 (69.9%)49 (52.7%)
Instant nutrition assessment grade
 157 (65.5%)63 (72.4%)31 (62.0%)38 (76.0%)97 (67.4%)95 (66.0%)58 (62.3%)52 (55.9%)
 225 (28.7%)22 (25.3%)15 (30.0%)12 (24.0%)38 (26.4%)2 (1.4%)23 (24.7%)0 (0.0%)
 32 (2.3%)0 (0.0%)3 (4.0%)0 (0.0%)1 (0.6%)46 (31.9%)2 (2.2%)41 (44.1%)
 43 (3.4%)2 (2.3%)3 (4.0%)0 (0.0%)8 (5.6%)1 (0.7%)10 (10.8%)0 (0.0%)
Surg Metab Nutr 2019;10:46-53 https://doi.org/10.18858/smn.2019.10.2.46
© 2019 Surg Metab Nutr